Skip to main content
Fig. 7 | Stem Cell Research & Therapy

Fig. 7

From: JKAMP inhibits the osteogenic capacity of adipose-derived stem cells in diabetic osteoporosis by modulating the Wnt signaling pathway through intragenic DNA methylation

Fig. 7

Overexpression of Jkamp increases the osteogenic ability of DOP-ASCs. a, b Immunofluorescence staining of RUX2 and OPN proteins in DOP-ASC after 3 days of osteoinduction. c Alizarin red staining of DOP-ASCs after 14 days of osteoinduction. d, e ALP staining of DOP-ASCs after 3 and 5 days of osteoinduction. c Osteoinduction for 3 days. d Osteoinduction for 5 days

Back to article page